Zeng W, Tian K Q, Pan Y Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Sep;32(17):1354-1356. doi: 10.13201/j.issn.1001-1781.2018.17.015.
Neuroendocrine carcinoma(NEC) of the tonsil is extremely rare that exhibits highly malignant and poorly prognosis. Only a few of case reports and the optial treatment is still uncertain. Here, the current study presents a case of 60-year-old male with neck mass rapidly growing for four months. It was diagnosed a primary tonsil neuroendocrine carcinoma. And he was treated by one cycle of cisplatin and etoposide. It had no effect and the tumor was rapidly progressed. With review of the literatures, the nomenclature, clinicopathological characteristics and treatment modalities of this rare tumor are discussed.
扁桃体神经内分泌癌（NEC）极为罕见，具有高度恶性且预后较差。仅有少数病例报告，最佳治疗方法仍不明确。在此，本研究报告了一例60岁男性患者，其颈部肿块迅速增大4个月。经诊断为原发性扁桃体神经内分泌癌。患者接受了一个周期的顺铂和依托泊苷治疗，但无效，肿瘤迅速进展。通过文献复习，对这种罕见肿瘤的命名、临床病理特征及治疗方式进行了讨论。
